About
3.80USD+0.12 +3.26%
Closed • Updated at 21:19 GMT+00:00Market Cap$229.60M
Volume571.6K
Beta1.04
RSI47.86
Gross Margin89.10%
Voyager Therapeutics, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 13 2026
Voyager ASGCT Late Breaker: Single IV Dose of VY1706 Well Tolerated, Reduced Tau in 3-Month GLP Toxicology Data; Clinical Trial in Alzheimer’s Disease Expected H2 2026
May 7 2026
Voyager Reports First Quarter 2026 Financial and Operating Results
Apr 27 2026
Voyager IV-Delivered CNS Gene Therapies Featured in Multiple Presentations at ASGCT 2026, Including Late Breaker on Tau-Targeted VY1706 for Alzheimer’s Disease
Mar 9 2026
Voyager Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
Feb 9 2026
Voyager to Present at Upcoming Investor Conferences
Community Chat
Ask AI
Try asking
Translate